Search icon

SCIEGEN PHARMACEUTICALS, INC.

Headquarter

Company Details

Name: SCIEGEN PHARMACEUTICALS, INC.
Jurisdiction: New York
Legal type: DOMESTIC BUSINESS CORPORATION
Status: Active
Date of registration: 28 Sep 2009 (15 years ago)
Entity Number: 3860966
ZIP code: 11788
County: Suffolk
Place of Formation: New York
Address: 89 ARKAY DR., HAUPPAUGE, NY, United States, 11788
Principal Address: 7 OSER AVE, HAUPPAUGE, NY, United States, 11788

Shares Details

Shares issued 200

Share Par Value 0

Type NO PAR VALUE

Links between entities

Type Company Name Company Number State
Headquarter of SCIEGEN PHARMACEUTICALS, INC., Alaska 10270644 Alaska
Headquarter of SCIEGEN PHARMACEUTICALS, INC., Alabama 000-371-899 Alabama

Unique Entity ID

Unique Entity ID Expiration Date Physical Address Mailing Address
WH8BR7NRXLC5 2025-01-17 89 ARKAY DR, HAUPPAUGE, NY, 11788, 3727, USA 330 OSER AVE, HAUPPAUGE, NY, 11788, 3727, USA

Business Information

URL www.sciegenpharm.com
Congressional District 01
State/Country of Incorporation NY, USA
Activation Date 2024-01-22
Initial Registration Date 2020-07-17
Entity Start Date 2009-09-28
Fiscal Year End Close Date Sep 30

Service Classifications

NAICS Codes 325412

Points of Contacts

Electronic Business
Title PRIMARY POC
Name SIVA REDDY PALEMPALLI
Role COO
Address 330 OSER AVE, HAUPPAUGE, NY, 11788, USA
Title ALTERNATE POC
Name JOSEPH ROMANO
Role CFO
Address 7 OSER AVE, HAUPPAUGE, NY, 11788, USA
Government Business
Title PRIMARY POC
Name SIVA REDDY PALEMPALLI
Role COO
Address 330 OSER AVE, HAUPPAUGE, NY, 11788, USA
Title ALTERNATE POC
Name JOSEPH ROMANO
Role CFO
Address 7 OSER AVE, HAUPPAUGE, NY, 11788, USA
Past Performance
Title PRIMARY POC
Name JOSEPH ROMANO
Role CFO
Address 7 OSER AVE, HAUPPAUGE, NY, 11788, USA
Title ALTERNATE POC
Name SIVA REDDY PALEMPALLI
Role COO
Address 330 OSER AVE, HAUPPAUGE, NY, 11788, USA

Chief Executive Officer

Name Role Address
DR. P. M. REDDY Chief Executive Officer 7 OSER AVE, HAUPPAUGE, NY, United States, 11788

DOS Process Agent

Name Role Address
THE CORPORATION DOS Process Agent 89 ARKAY DR., HAUPPAUGE, NY, United States, 11788

History

Start date End date Type Value
2023-10-17 2023-10-17 Address 7 OSER AVE, HAUPPAUGE, NY, 11788, USA (Type of address: Chief Executive Officer)
2017-07-10 2023-10-17 Address 89 ARKAY DRIVE, HAUPPAUGE, NY, 11788, USA (Type of address: Service of Process)
2016-08-11 2017-07-10 Address 7 OSER AVE, HAUPPAUGE, NY, 11788, USA (Type of address: Service of Process)
2011-10-04 2023-10-17 Address 7 OSER AVE, HAUPPAUGE, NY, 11788, USA (Type of address: Chief Executive Officer)
2010-11-18 2023-10-17 Shares Share type: PAR VALUE, Number of shares: 100000, Par value: 0.01
2009-09-28 2016-08-11 Address 620 OLD WILLETS PATH, HAUPPAUGE, NY, 11788, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
231017000302 2023-10-17 BIENNIAL STATEMENT 2023-09-01
221007001571 2022-10-07 BIENNIAL STATEMENT 2021-09-01
200603060587 2020-06-03 BIENNIAL STATEMENT 2019-09-01
180612006016 2018-06-12 BIENNIAL STATEMENT 2017-09-01
170710000349 2017-07-10 CERTIFICATE OF CHANGE 2017-07-10
160811006455 2016-08-11 BIENNIAL STATEMENT 2015-09-01
130911006236 2013-09-11 BIENNIAL STATEMENT 2013-09-01
111004002483 2011-10-04 BIENNIAL STATEMENT 2011-09-01
101118000487 2010-11-18 CERTIFICATE OF AMENDMENT 2010-11-18
090928000367 2009-09-28 CERTIFICATE OF INCORPORATION 2009-09-28

Awards

Contract Type Award or IDV Flag PIID Start Date Current End Date Potential End Date
No data IDV SPE2D221D0129 2021-06-16 No data No data
Unique Award Key CONT_IDV_SPE2D221D0129_9700
Awarding Agency Department of Defense
Link View Page

Award Amounts

Obligated Amount 0.00
Potential Award Amount 3682375.00

Description

Title 4610070810!MANUFACTURE/DISTRIBUTOR BR-PH
NAICS Code 325412: PHARMACEUTICAL PREPARATION MANUFACTURING
Product and Service Codes 6505: DRUGS AND BIOLOGICALS

Recipient Details

Recipient SCIEGEN PHARMACEUTICALS INC
UEI WH8BR7NRXLC5
Recipient Address UNITED STATES, 89 ARKAY DR, HAUPPAUGE, SUFFOLK, NEW YORK, 117883727

Date of last update: 26 Nov 2024

Sources: New York Secretary of State